相关实验视频

Updated: May 10, 2025

Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions

Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions

Published on: September 25, 2018

针对位点的抗体向KRAS蛋白的驱动突变

Xiaofeng Li¹, Qiana Mendez¹, Cassandra Chapados¹

¹Abbratech, 25 Business Park Drive, Suite C, Branford, CT 06405, USA.

New biotechnology

|April 19, 2025

概括

研究人员开发了高度特定的单克隆抗体 (mAbs),向KRAS G12D突变,这是许多癌症的常见驱动因素. 这些抗体表现出强烈的亲和力和特异性,为新的诊断和治疗策略铺平了道路.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
免疫学免疫学免疫学

背景情况:

基尔斯顿大鼠肉瘤病毒性瘤基因同源 (KRAS) 是人类癌症中最常发生突变的瘤基因,约有30%的瘤存在.
在KRAS中的突变,特别是G12编码子中的突变,是瘤发生的关键驱动因素.
对KRAS的突变特异性抗体的开发落后于抑制剂的开发.

研究的目的:

开发针对KRAS G12D瘤驱动突变的新型,位点定向的单克隆抗体 (mAbs).
描述这些新开发的mAbs对KRAS G12D的亲和力和特异性.
评估这些mAbs在KRAS突变癌症的诊断和治疗应用中的潜力.

主要方法:

利用Epivolve技术开发定位单克隆抗体.
使用平衡解离常数 (K_D) 评估抗体结合亲和力.
通过用纯化的蛋白质和细胞系进行西部斑分析,以及通过癌细胞中的免疫细胞化学来确认特异性.

主要成果:

开发了位点定向的mAbs,对KRAS G12D具有很高的结合亲和力,在纳米分子范围内表现出K_D.
与野生型KRAS相比,对KRAS G12D的亲和力超过1000倍.
在癌细胞中确认了高特异性和验证了与内源性KRAS G12D的同定位.

结论:

开发的定位mAbs对KRAS G12D突变具有很高的亲和力和特异性.
这些mAbs代表了促进诊断应用的有希望的工具.
这些发现支持这些mAbs在开发针对KRAS驱动癌症的向疗法的潜在实用性.

关键词:

抗体是对抗体的一种.发生性发育发生性发育发生性发育免疫接种免疫接种克拉斯 (Kras) 是一个国家.突变突变是一种突变.

更多相关视频

Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay

Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay

Published on: August 14, 2018

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein

Published on: January 16, 2020

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

The Ras Gene

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...